Favorable outcome of immunotherapy in a rare subtype of hepatocellular carcinoma: a case report and literature review

Favorable outcome of immunotherapy in a rare subtype of hepatocellular carcinoma: a case report and literature review

Scirrhous hepatocellular carcinoma (S-HCC) represents an uncommon subtype of HCC. During radiological evaluation this unique subtype is frequently mistaken as cholangiocarcinoma, fibrolamellar HCC, or metastatic adenocarcinoma. Here, we present the case of a 50-year-old woman with a large hepatic ma...

Full description

Bibliographic Details
Main Authors: Anita Archwamety, Nique Kunapinun, Sirinart Sirinvaravong, Piyaporn Apisarnthanarak, Charuwan Akewanlop, Krittiya Korphaisarn
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Oncology
Subjects:
scirrhous HCC
scirrhous hepatocellular carcinoma
immune checkpoint inhibitor
immune related adverse event (irAE)
hepatocellular carcinoma (HCC)
type 1 DM
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1358804/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1358804/full

Similar Items